In addition, chronic granulomatous disease caused by deficiency of NADPH oxidase may lead to multiple clinical manifestations in virtually all tissues/organs, from the liver to the CNS (see [75] for review). This evidence concerns the gene FMO5 and chronic granulomatous disease.